
Independent science and medical journalism
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 319 | Subscribers | Read | blog.maryannedemasi.com |
Curious about how many subscribers Maryanne Demasi, reports has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
How this newsletter ranks in the official Substack charts.
| #34 | |
| #20 |
Recent posts by this newsletter. Browse the email archive.
An unprecedented admission inside the FDA has shattered years of government assurances about Covid vaccine safety — and may signal the most consequential overhaul of vaccine oversight yet.
Pfizer’s mRNA flu shot failed in the over-65s, but the New England Journal of Medicine never published the data — prompting calls for accountability.
ANALYSIS: Pfizer’s mRNA flu shot was supposed to revive confidence in the platform. Instead, its own trial results reinforce the view that mRNA is still nowhere near ready for prime time.
CDC advisers voted for patient choice on Covid shots. But the old establishment claims it’s an “abdication of responsibility.”
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
Maryanne Demasi PhD is an investigative journalist who writes for online media and top tiered medical journals. For over a decade, she was a TV presenter for the Australian Broadcasting Corporation (ABC).
You can find recent issues that have been published by Maryanne Demasi, reports on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Maryanne Demasi, reports, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Maryanne Demasi, reports as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Maryanne Demasi, reports using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like Maryanne Demasi, reports. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.